2-溴-6-(三氟甲氧基)苯甲酸 | 403646-46-8

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-6-(三氟甲氧基)苯甲酸
• 中文别名: 2-溴-6-三氟甲氧基苯甲酸
• 英文名称: 3-bromo-6-(trifluoromethoxy)benzoic acid
• 英文别名: 2-bromo-6-(trifluoromethoxy)benzoic acid；2-bromo-6-[(trifluoromethyl)oxy]benzoic acid
• CAS: 403646-46-8
• 化学式: C₈H₄BrF₃O₃
• 分子量: 285.017
• InChiKey: ZCMUHYSGAOIGEG-UHFFFAOYSA-N

物化性质

• 沸点：
  270.2±40.0 °C(Predicted)
• 密度：
  1.797±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 海关编码：
  2918990090
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-bromo-6-(trifluoromethoxy)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-bromo-6-(trifluoromethoxy)benzoic acid
CAS number: 403646-46-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H4BrF3O3
Molecular weight: 285.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

概述

2-溴-6-(三氟甲氧基)苯甲酸可用作医药合成中间体。它可以通过将2-氨基-6-(三氟甲基)苯甲酸作为起始反应原料，在亚硝酸钠与溴化钾的作用下制备得到。

应用

作为一种羧酸类衍生物，2-溴-6-(三氟甲氧基)苯甲酸可用于制备吡唑酰胺衍生物。它在治疗多种疾病、病症或失调（例如过敏性失调、炎性失调和免疫系统失调）方面具有一定的用途。

反应信息

• 作为反应物：
  描述：

  2-溴-6-(三氟甲氧基)苯甲酸 在 硼烷四氢呋喃络合物 、 甲醇 作用下， 以 四氢呋喃 为溶剂， 生成 2-溴-6-(三氟甲氧基)苯甲醇
  参考文献：
  名称：

  [EN] N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS
  [FR] CARBOXAMIDES N-PYRAZOLYL EN TANT QU'INHIBITEURS DU CANAL CRAC

  摘要：

  本发明涉及酰胺化合物，其制备方法，含有这些化合物的药物组合物，以及它们在治疗过敏性疾病、炎症性疾病和免疫系统疾病等疾病、状况或障碍中的应用。

  公开号：

  WO2010122089A1
• 作为产物：
  描述：

  二氧化碳 、 3-三氟甲氧基溴苯 在 正丁基锂 、 二异丙胺 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 2.0h， 以90%的产率得到2-溴-6-(三氟甲氧基)苯甲酸
  参考文献：
  名称：

  1,2-二脱氢-3-和-4-（三氟甲氧基）苯：1-和2-（三氟甲氧基）萘的“芳炔”路线

  摘要：

  在 -100 摄氏度下用二异丙基氨基锂 (LDA) 处理 1-溴-2-（三氟甲氧基）苯后，生成 3-溴-2-（三氟甲氧基）苯基锂。它可以像这样被捕获，但是当温度升高时会异构化以提供 2-溴-6-(三氟甲氧基)苯基锂。升至 -75 摄氏度。后一种中间体可直接由1-溴-3-(三氟甲氧基)苯得到。1-溴-4-（三氟甲氧基）苯在 -100 摄氏度时生成 5-溴-2-（三氟甲氧基）苯基锂，但在 -75 摄氏度时它会缓慢地消除溴化锂，从而释放出 1,2-脱氢-4-（三氟甲氧基）苯基锂）苯。同理，1-溴-3-(三氟甲氧基)苯可以生成1,2-脱氢-3-(三氟甲氧基)苯。两种芳烃都可以用呋喃原位截获。生成的 [4+2] 环加合物可以用锌粉还原，得到 1- 和 2-（三氟甲氧基）萘，它们可以进行酸催化异构化以产生三氟甲氧基-1-萘酚，或者它们可以被溴化以提供 vic-二溴衍生物。后者化合物的碱促进脱溴化氢。生成

  DOI：

  10.1002/1099-0690(200111)2001:21<3991::aid-ejoc3991>3.0.co;2-j

文献信息

• HETEROCYCLIC COMPOUNDS AND USES THEREOF
  申请人：INFINITY PHARMACEUTICALS, INC.

  公开号：US20130267521A1

  公开（公告）日：2013-10-10

  Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

  本发明描述了调节激酶活性的化合物和药物组合物，包括PI3激酶活性，以及用于治疗与激酶活性相关的疾病和状况的化合物、药物组合物和方法，包括PI3激酶活性。
• [EN] MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF<br/>[FR] MODULATEURS DES RÉCEPTEURS 5-HT, ET PROCÉDÉS D'UTILISATION CORRESPONDANTS
  申请人：ABBOTT LAB

  公开号：WO2010135560A1

  公开（公告）日：2010-11-25

  The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I), wherein R1,R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

  本申请涉及式(I)的芳基和杂芳基融合的十氢吡咯环庚烷、八氢氧杂环己烯基吡咯、八氢吡咯噻环庚烷二氧化物、十氢环庚[c]吡咯和八氢环庚[c]吡咯衍生物，其中R1、R2、R3、R4、R5、A、Y1、Y2和Y3如规范中所定义。本申请还涉及包含这些化合物的组合物、制备这些化合物的方法，以及使用这些化合物和组合物治疗疾病症状的方法，以及鉴定这些化合物的方法。
• [EN] HETEROCYCLIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
  申请人：INFINITY PHARMACEUTICALS INC

  公开号：WO2013154878A1

  公开（公告）日：2013-10-17

  Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

  本文描述了调节激酶活性，包括PI3激酶活性的化合物和制药组合物，以及与激酶活性，包括PI3激酶活性相关的疾病和病症的治疗方法、化合物和制药组合物。
• N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS
  申请人：Allen David George

  公开号：US20120053150A1

  公开（公告）日：2012-03-01

  The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.

  本发明涉及酰胺化合物、其制备方法、含有这些化合物的药物组合物以及它们在治疗过敏性疾病、炎症性疾病和免疫系统疾病等疾病、症状或障碍中的应用。
• MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF
  申请人：Akritopoulou-Zanze Irini

  公开号：US20110118231A1

  公开（公告）日：2011-05-19

  The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , A, Y 1 , Y 2 , and Y 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

  本申请涉及公式（I）的芳基和杂环芳基融合的十氢吡咯-氮杂环庚烷、八氢氧杂环吡咯、八氢吡咯硫杂环庚烷二氧化物、十氢环庚烷[c]吡咯和八氢环庚烷[c]吡咯衍生物，其中R1、R2、R3、R4、R5、A、Y1、Y2和Y3如规范中所定义。本申请还涉及包含这些化合物的组合物、制备这些化合物的方法、使用这些化合物和组合物治疗疾病状况的方法，以及识别这些化合物的方法。